Health insurers in the United States have recently reported strong first-quarter results, indicating a more stable outlook for medical costs after facing significant pressure in recent years. Analysts on Wall Street are cautiously optimistic but are waiting to see another similar quarter before fully believing in the industry’s recovery.
Over the past three years, rising medical costs across government-sponsored health plans have weighed down the sector, leading to a decline in the S&P managed care index. However, major health insurers such as UnitedHealth Group, Cigna, Humana, Elevance Health, and Centene have reported first-quarter results that exceeded analysts’ expectations. They have also expressed confidence in their ability to manage higher costs more effectively.
According to Oppenheimer analyst Michael Wiederhorn, this marks the best performance for insurers since the onset of the COVID-19 pandemic, during which they benefited from reduced medical services utilization. Insurers typically report stronger earnings in the first quarter as many members have not yet reached their deductibles, resulting in fewer claims payouts.
While some analysts remain cautious, noting that lower costs in the quarter could be attributed to a milder respiratory season, others are more positive about the industry’s performance. UBS analyst AJ Rice believes that cost trends are stabilizing, and there is potential for further positive earnings estimate revisions.
Looking ahead, analysts are keeping a close eye on the upcoming quarter to assess the sustainability of the current trends. Leerink Partners analyst Whit Mayo emphasized the importance of the second quarter as a true test for health insurers, as claims typically peak in May. UnitedHealth Chief Financial Officer Wayne DeVeydt highlighted the significance of monitoring April and May to gain clarity on claims payments and overall performance.
While some one-off factors, such as a weaker flu season and weather disruptions, may have contributed to lower costs in the first quarter, analysts like Cantor Fitzgerald’s Sarah James believe that there is underlying strength in the industry. Temporary impacts on services like eye care and GI procedures have left insurers handling more serious cases, indicating a shift towards more critical care.
Overall, analysts are cautiously optimistic about the health insurance industry’s performance in the coming months. While there are concerns about the sustainability of the current trends, there is growing confidence that medical cost trends may finally be improving after years of pressure. The industry’s ability to navigate these challenges and adapt to changing conditions will be crucial in determining its long-term success.
